Housed within the Siteman Cancer Center, the Biologic Therapy Core Facility (BTCF) partners with physicians and scientists to manufacture, characterize, and release complex, clinical-grade cell and gene therapy products, imaging agents, and other biologics to support early-phase clinical trials. The BTCF also supports cellular (e.g. hematopoietic stem cell selections) and tissue therapies (e.g. parathyroid cryopreservation) […]
ICTS-supported facility accelerates translation of promising research into improving outcomes for cancer and other related diseases
